<p>A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths</p>
GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 hormone, which is involved in regulating appetite and insulin secretion. These drugs are primarily used for the treatment of type 2 diabetes and obesity, as they help to reduce food intake and promote weight loss.
Substance use disorders are conditions characterized by an individual's inability to control their use of substances, such as alcohol or drugs, leading to significant impairment or distress. These disorders can have serious health consequences and often require comprehensive treatment approaches, including behavioral therapies and medications.